Centene lifts annual profit forecast, reports upbeat third-quarter results

What happened

Centene raised its annual profit forecast and reported better-than-expected third-quarter results. It now expects 2026 adjusted profit above $5.20 per share, up from a prior forecast of more than $4.80, while its medical loss ratio stayed at 92.7%.

Confirmed

Global impact / market context

A higher profit forecast signals Centene expects earnings to recover faster than previously thought, helped by cost controls. For investors, this suggests the company is managing rising medical costs better, which can support the stock and ease concerns about profitability.

Analyst inference

Health insurers have struggled with rising medical costs as patients seek more care, squeezing profits. Centene's medical loss ratio, which means the share of premiums spent on care, matched last year and beat analyst expectations, suggesting cost pressure may be stabilizing.

Analyst inference

What to watch

1. Centene's medical loss ratio was 92.7%, unchanged from last year and below the 92.84% analysts expected. Confirmed
2. Watch whether Centene's cost controls keep its medical loss ratio stable, since a rising ratio would mean more premiums spent on care and less profit. Proposed
3. If Centene delivers the higher 2026 profit, investor confidence in its earnings recovery could grow, but missing the $5.20 target may renew worries about medical costs. Analyst inference

Evidence

• Original source link unavailable